Copyright
©The Author(s) 2025.
World J Clin Oncol. May 24, 2025; 16(5): 105881
Published online May 24, 2025. doi: 10.5306/wjco.v16.i5.105881
Published online May 24, 2025. doi: 10.5306/wjco.v16.i5.105881
Table 1 Overview of studies assessing outcomes of liver resection vs ablation in hepatocellular carcinoma
Ref. | Study type | Pre-PSM sample size | Post-PSM sample size | Subgroups | Subgroup type |
Bai et al[10] | Retrospective comparative study | 2197 | 1346 | Yes | Microvascular invasion risk |
Chong et al[11] | Retrospective comparative study | 214 | 118 | No | |
Chua et al[12] | Retrospective comparative study | 219 | 104 | No | |
Gory et al[13] | Retrospective comparative study | 146 | Yes | Tumor size (< 3 cm; < 5 cm) | |
He et al[14] | Retrospective comparative study | 435 | 259 | No | |
Hsiao et al[15] | Retrospective comparative study | 387 | No | ||
Kim et al[16] | Retrospective comparative study | 365 | 122 | Yes | AFP level > 100 ng/mL (yes; no) |
Lai et al[17] | Retrospective comparative study | 94 | Yes | Age (< 60 years; > 60 years) | |
Liu et al[19] | Retrospective comparative study | 836 | 600 | Yes | Risk of recurrence (high; low) |
Liu et al[18] | Retrospective comparative study | 237 | 158 | No | |
Lu et al[20] | Retrospective comparative study | 332 | 240 | Yes | Milan criteria (yes; no) and recurrence within 2 years (yes; no) |
Ng et al[21] | Randomized clinical trial | 218 | No | ||
Qiu et al[22] | Retrospective comparative study | 259 | 154 | No | |
Song et al[24] | Retrospective comparative study | 156 | Yes | Tumor size (< 2 cm; 2-4 cm) | |
Song et al[23] | Randomized clinical trial | 150 | No | ||
Takayasu et al[25] | Retrospective comparative study | 853 | 732 | No | |
Vitale et al[26] | Retrospective comparative study | 720 | 693 | No | |
Wang et al[27] | Retrospective comparative study | 672 | 420 | Yes | Age (60-64 years; 65-72 years; > 73 years) |
Wei et al[28] | Retrospective comparative study | 382 | Yes | Pre-operatorial imaging traits | |
Xia et al[29] | Randomized clinical trial | 217 | Yes | Tumor size (< 3 cm; > 3 cm) and AFP > 200 ng/mL (yes; no) | |
Ye et al[30] | Retrospective comparative study | 388 | 308 | Yes | Tumor size (3-4 cm; 4-5 cm) |
Zeng et al[31] | Retrospective comparative study | 1632 | 1142 | Yes | Tumor size (0-2 cm; 2-5 cm; > 5 cm) and age (< 65 years; > 65 years) |
Zhong et al[32] | Retrospective comparative study | 847 | 454 | No |
- Citation: Cicerone O, Mantovani S, Oliviero B, Basilico G, Corallo S, Quaretti P, Maestri M. Navigating the evidence for hepatocellular carcinoma treatment: Surgery vs radiofrequency ablation through sentiment and meta-analysis. World J Clin Oncol 2025; 16(5): 105881
- URL: https://www.wjgnet.com/2218-4333/full/v16/i5/105881.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i5.105881